New HIV-1 Inhibitor Shows Promise
Author Information
Author(s): Huang Yang, Wang Xiaowei, Yu Xiaoling, Yuan Lin, Guo Ying, Xu Weisi, Liu Tiejun, Liu Junyi, Shao Yiming, Ma Liying
Primary Institution: State Key Laboratory for Infection Disease Prevention and Control, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (CDC), China
Hypothesis
Can 9-phenylcyclohepta[d]pyrimidinedione derivatives effectively inhibit HIV-1?
Conclusion
BmPCP is effective against a broad spectrum of HIV-1 strains and can serve as a lead compound for new anti-HIV-1 drugs.
Supporting Evidence
- BmPCP showed IC50 values of 0.34 μM and 1.96 μM against different HIV-1 strains.
- The selectivity index of BmPCP ranged from 67 to 266 in various cell types.
- BmPCP effectively inhibited HIV-1 infection in laboratory-adapted strains and clinical isolates.
Takeaway
A new compound called BmPCP can help fight HIV by stopping the virus from making copies of itself.
Methodology
The study involved testing the antiviral activity of BmPCP against various HIV-1 strains in different cell types.
Limitations
BmPCP was less effective against NNRTI drug-resistant strains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website